Concepedia

Caroline A. Lee

CA

Statistics

Publications

23

Citations

1.7K

H-Index

19

Active since

1989

Affiliations

Pfizer (United States)(Current)

University of Washington

Agouron Institute

General Atomics (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Caroline A. Lee is an author at Pfizer (United States) specializing in pharmacology, medicine, and pharmacokinetics.

Publications per year

1989–2024

23

Publications

23

Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by Human CYP3A4

Kenneth E. Thummel, Caroline A. Lee, Kent L. Kunze et al. · Biochemical Pharmacology · 1993 · 294 citations

, , +7

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P<sub>1</sub> Lactam Moieties as <scp>l</scp>-Glutamine Replacements

Peter S. Dragovich, Thomas J. Prins, Ru Zhou et al. · Journal of Medicinal Chemistry · 1999 · 189 citations · Full text

, , +16

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics

Peter S. Dragovich, Thomas J. Prins, Ru Zhou et al. · Journal of Medicinal Chemistry · 2002 · 142 citations · Full text

, , +17

Identification of Novel Substrates for Human Cytochrome P450 2J2

Caroline A. Lee, David Neul, Andrea Clouser-Roche et al. · Drug Metabolism and Disposition · 2009 · 135 citations

, , +10

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing Peptidomimetics

Peter S. Dragovich, Thomas J. Prins, Ru Zhou et al. · Journal of Medicinal Chemistry · 2003 · 115 citations

, , +17

1–5 of 23